Incomplete Evidence of Bone Density Normalization Following Long-Term Reproductive Hormone Treatment in Men With Hypogonadotropic Hypogonadism - Takeaways - MDSpire

Incomplete Evidence of Bone Density Normalization Following Long-Term Reproductive Hormone Treatment in Men With Hypogonadotropic Hypogonadism

  • By

  • Nipun Lakshitha de Silva

  • Elizabeth Hyams

  • Bonnie Grant

  • Paras Dixit

  • Rajdeep Bassi

  • Paul Bassett

  • Alexander N Comninos

  • Channa N Jayasena

  • October 1, 2025

  • 0 min

Share

  • 1

    Men with hypogonadotropic hypogonadism (HH) exhibit low bone mineral density (BMD), particularly in the lumbar spine and femoral neck.

  • 2

    Hormonal treatment improves BMD in men with HH, but normalization of BMD may not occur, especially in those with congenital hypogonadotropic hypogonadism.

  • 3

    Younger age at treatment initiation, partial HH, and higher serum testosterone and estradiol levels correlate with better BMD outcomes.

  • 4

    The prevalence of fractures is high among men with HH, although fracture data is limited in existing studies.

  • 5

    Current evidence from small observational studies indicates insufficient data on the long-term effects of reproductive hormone therapy on BMD in men with HH.

Original Source(s)

Related Content